Patents by Inventor Kathryn E. Rogers

Kathryn E. Rogers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6562865
    Abstract: This invention relates to a pharmaceutical composition comprising a combination of a tramadol material and an anticonvulsant drug and to the pharmacological use of the composition in treating conditions of pain and neurologic or psychiatric disorders. The composition produces a combination product having improved properties, requiring less of each ingredient and producing a synergistic effect.
    Type: Grant
    Filed: August 9, 2000
    Date of Patent: May 13, 2003
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Ellen E. Codd, Rebecca P. Martinez, Kathryn E. Rogers
  • Patent number: 6369228
    Abstract: Aroyl aminoacyl pyrroles are pharmaceutically useful in treating neuropathic pain, which includes utility for the treatment of neuropathic pain.
    Type: Grant
    Filed: February 5, 2001
    Date of Patent: April 9, 2002
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: John R. Carson, Philip M. Pitis, Kathryn E. Rogers
  • Publication number: 20010044452
    Abstract: Aroyl aminoacyl pyrroles are pharmaceutically useful in treating neuropathic pain, which includes utility for the treatment of neuropathic pain.
    Type: Application
    Filed: February 5, 2001
    Publication date: November 22, 2001
    Inventors: John R. Carson, Philip M. Pitis, Kathryn E. Rogers
  • Patent number: 6191142
    Abstract: Aroyl aminoacyl pyrroles are pharmaceutically useful in treating neuropathic pain, which includes utility for the treatment of neuropathic pain.
    Type: Grant
    Filed: February 17, 2000
    Date of Patent: February 20, 2001
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: John R. Carson, Philip M. Pitis, Kathryn E. Rogers
  • Patent number: 4460560
    Abstract: Anthracycline cancer drugs are covalently coupled to polymeric particles having a diameter of greater than about 0.5 microns to produce pharmaceutical preparations having enhanced cytostatic activity. The coupling of drugs to polymeric carriers shows increased activity against cancer cells, allows the bound drug to retain its cytostatic activity after repeated uses and shows an increase in activity against drug resistant cells.
    Type: Grant
    Filed: June 18, 1982
    Date of Patent: July 17, 1984
    Assignee: University of Southern California
    Inventors: Zoltan A. Tokes, Kathryn E. Rogers, Alan Rembaum